You are here:  Home » Research Funding » Funding News » NINDS Notes - November 2010 » 

Skip secondary menu

Funding News - CounterACT

Archive folder iconHistorical Data

  • The information on this page is for historical and research purposes only.
  • For the most current NINDS funding announcements, please see the NINDS list of Active Funding Initiatives or Follow Us on Twitter for the latest funding news.

NINDS encourages grant applications for exploratory or developmental translational research on countermeasures against chemical threats (CounterACT). This announcement is made together with 5 other NIH components.

Chemical threats are toxic chemicals that could be released by a deliberate terrorist attack, by accident, or by natural disaster, causing mass casualties. NIH has developed a comprehensive CounterACT program that supports basic, translational, and clinical research aimed at discovering and/or identifying better medical countermeasures against chemical threats, and their movement through the regulatory process. The program’s overarching goal is to enhance medical response capabilities during an emergency. This initiative supports exploratory and developmental translational research projects on therapeutics for reducing death and disease caused by exposure to chemical threats.

Letters of Intent Due January 4, 2011

Applications Due February 1, 2011

Potential applicants should contact Dr. David Jett, program director, Office of Translational Research, NINDS, at 301-496-6035 or jettd@ninds.nih.gov. For more information visit http://grants.nih.gov/grants/guide/pa-files/PAR-10-019.html.